argenx SE (EBR:ARGX)
619.20
+3.40 (0.55%)
Feb 21, 2025, 5:35 PM CET
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
€1,490,683
Profits / Employee
€31,469
Market Cap
37.62B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UCB SA | 9,083 |
Fagron NV | 3,282 |
Ion Beam Applications | 2,145 |
Nyxoah | 147 |
Onward Medical | 99 |
Hyloris Pharmaceuticals | 41 |
Sequana Medical NV | 62 |
Celyad Oncology | 19 |
argenx SE News
- 1 day ago - argenx SE (ARGX) Announces Upcoming Conference Call for 2024 Financial Results - GuruFocus
- 2 days ago - argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - GlobeNewsWire
- 2 days ago - Argenx Vaults 3,659% With Profit Growth Seen In Triple Digits; Earnings Next As Stock Hits Highs - Investor's Business Daily
- 4 weeks ago - argenx: Lofty Valuation Diminishes Appeal Amid Autoimmune Expansion (Rating Downgrade) - Seeking Alpha
- 5 weeks ago - Argenx cut to Sell at Deutsche Bank on valuation - Seeking Alpha
- 5 weeks ago - Immunology company argenx estimates higher product net sales from last year - Seeking Alpha
- 5 weeks ago - argenx SE (ARGX) Announces Preliminary 2024 Financial Results and Strategic Priorities for 2025 - GuruFocus
- 5 weeks ago - argenx Highlights 2025 Strategic Priorities - GlobeNewsWire